Klow

KLOW is a four-compound research blend combining GHK-Cu, BPC-157, TB-500, and KPV within a single 80 mg formulation.

This blend is intended for controlled laboratory investigations involving copper-peptide signaling, extracellular-matrix activity, fibroblast behavior, actin-related cellular processes, cellular migration, inflammatory signaling, and epithelial-response models.

Composition per vial:

• GHK-Cu: 50 mg
• BPC-157: 10 mg
• TB-500: 10 mg
• KPV: 10 mg
• Total content: 80 mg

KPV is the tripeptide lysine-proline-valine and has been investigated primarily in preclinical models involving inflammatory and epithelial signaling. Evidence for the complete KLOW formulation remains preclinical, and no claim of therapeutic benefit or compound synergy is made.

For laboratory research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.